FDMT Operating Cash Flow (Statement)
4D Molecular Therapeutics Inc · Operating Cash Flow (Statement)
FDMT Operating Cash Flow (Statement)
Latest reported-$70.00Mperiod ending
FDMT Quarterly Cash from Operations (-$3.21M → -$70.00M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
FDMT operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -69,999,000 | |
| -68,125,000 | |
| 28,551,000 | |
| -46,498,000 | |
| -43,377,000 | |
| -47,758,000 | |
| -45,863,000 | |
| -29,391,000 | |
| -30,243,000 | |
| -29,088,000 | |
| -24,650,000 | |
| -1,171,000 | |
| -22,065,000 | |
| -27,906,000 | |
| -22,214,000 | |
| -21,017,000 | |
| -19,904,000 | |
| -23,550,000 | |
| -21,836,000 | |
| -15,721,000 | |
| -16,205,000 | |
| -15,372,000 | |
| -17,499,000 | |
| -13,371,000 | |
| -6,169,000 | |
| -13,870,000 | |
| -8,686,000 | |
| -10,857,000 | |
| -8,584,000 | |
| -8,584,000 | |
| -4,915,000 | |
| -4,915,000 | |
| -3,211,000 | |
| -3,211,000 |